Grifols Sa's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2025 to a ratio of 11.56, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the fourth quarter 2025. Average receivable collection period, for the Grifols Sa in Dec 31 2025 quarter, has decreased to 32 days, compared to 34 days, in the 0 quarter.

If we take a look into Healthcare sector 549 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2025 from 0 to 3735.

What is Receivable Turnover Ratio?
What is Grifols Sa Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

GRFS Receivables Turnover Ratio	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2024) IV. Quarter
Y / Y Receivable Change	-7.72 %	-7.72 %	-7.72 %	-7.72 %	9.35 %
Y / Y Revenue Change	4.32 %	-	-	-	-
Receivable Turnover Ratio (TTM)	11.56	10.85	10.63	10.42	10.22
GRFS's Total Ranking	# 3735	# 0	#	#	#
Accounts Receivable average collection period days	32	34	34	35	36
Seq. Receivable Change	0 %	0 %	0 %	-7.72 %	0 %
Seq. Revenue Change	-	-	-	-	-

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 182
Healthcare Sector	# 550
Overall Market	# 3735

Receivable Turnover Ratio Statistics
High	Average	Low
8.56	5.23	1.91
(Dec 31 2024)		(Dec 31 2025)

GRFS Company Profile • Back to GRFS Efficiency Comparisons • Compare GRFS Receivables Turnover Ratio to its Competitors

Financial Statements
Grifols Sa's Accounts Receivable	$ 729 Millions	Visit GRFS's Balance sheet
Grifols Sa's Sales TTM	$ 8,427 Millions	Visit GRFS's Income Statement
Sources of GRFS's Revenues		Visit GRFS's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
GRFS's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
GRFS's Growth Rates	GRFS's Roa	GRFS's Inventory Turnover Ratio	GRFS's Dividend Comparisons
GRFS's Profitability Ratios	GRFS's Roi	GRFS's Asset Turnover Ratio	GRFS's Dividend Growth
GRFS's Valuation Ratios	GRFS's Roe	GRFS's Financial Strength Ratios	GRFS's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2025	Receivable at quarter ending Dec 31 2025
U S Physical Therapy Inc	30.83	$ 780.990 Millions	$ 25.331 Millions
Invo Fertility Inc	30.16	$ 6.841 Millions	$ 0.227 Millions
Innovative Eyewear Inc	28.53	$ 2.662 Millions	$ 0.093 Millions
Aesthetic Medical International Holdings Group Limited	28.50	$ 106.636 Millions	$ 3.742 Millions
Puretech Health Plc	28.24	$ 4.659 Millions	$ 0.165 Millions
Evotec Se	26.89	$ 882.978 Millions	$ 32.835 Millions
Electrocore Inc	26.63	$ 31.800 Millions	$ 1.194 Millions
Innovage Holding Corp	26.44	$ 915.371 Millions	$ 34.626 Millions
Premier Air Charter Holdings Inc	26.15	$ 31.878 Millions	$ 1.219 Millions
Biontech Se	25.93	$ 3,214.288 Millions	$ 123.984 Millions
Polomar Health Services, Inc.	25.80	$ 0.648 Millions	$ 0.025 Millions
Cv Sciences Inc	25.56	$ 11.388 Millions	$ 0.446 Millions
Keros Therapeutics Inc	24.31	$ 257.786 Millions	$ 10.604 Millions
Newgenivf Group Limited	23.64	$ 4.726 Millions	$ 0.200 Millions
Valneva Se	23.01	$ 195.618 Millions	$ 8.501 Millions
Legend Biotech Corporation	22.81	$ 1,028.900 Millions	$ 45.100 Millions
Longeveron Inc	22.20	$ 1.199 Millions	$ 0.054 Millions
Telix Pharmaceuticals Ltd	21.68	$ 803.794 Millions	$ 37.080 Millions
Lifemd Inc	21.48	$ 193.686 Millions	$ 9.018 Millions
Fonar Corporation	21.42	$ 106.031 Millions	$ 4.950 Millions
Neuraxis Inc	21.11	$ 3.569 Millions	$ 0.169 Millions
Biorestorative Therapies Inc	20.88	$ 0.360 Millions	$ 0.017 Millions
Arvinas Inc	19.93	$ 262.600 Millions	$ 13.175 Millions
Voyager Therapeutics Inc	19.59	$ 40.374 Millions	$ 2.061 Millions
Sonida Senior Living Inc	19.55	$ 381.141 Millions	$ 19.494 Millions
Siga Technologies Inc	19.47	$ 94.575 Millions	$ 4.856 Millions
Kiniksa Pharmaceuticals International Plc	19.45	$ 677.564 Millions	$ 34.828 Millions
Lipocine Inc	18.38	$ 1.977 Millions	$ 0.108 Millions
Wave Life Sciences Ltd	18.34	$ 59.102 Millions	$ 3.223 Millions
Vystar Corporation	18.31	$ 0.055 Millions	$ 0.003 Millions

Date modified: 2026-06-22T16:58:57+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.